Full 2L QBank
Pharmacology Endocrinology 7d670224

All of the following statements about nateglinide are true except

A
Decreses post prandial hyperglycemia
B
Hypoglycemia is less common than with Sulfonylureas
C
It decreases insulin resistance
D
It acts by releasing insulin
High-Yield Explanation
Sulfonylureas, nateglinide and repaglinide act by inhibiting ATP sensitive K channels and thus resulting in release of insulin Like insulin All of these drugs can cause hypoglycemia However nateglinide therapy produce fewer episodes of hypoglycemia as compared to other oral insulin secretagogue Nateglinide bad repaglinide are sho acting and thus can reduce post prandial hyperglycemia

Related Pharmacology MCQs

Practice 2,00,000+ NEET PG Questions Free

Timed mock tests, mistake queue analytics, audio lectures & zero attempt limits on i❤️Exams.

Start Free Mock Test Now